-
公开(公告)号:ZA9308385B
公开(公告)日:1994-08-09
申请号:ZA9308385
申请日:1993-11-10
Applicant: GLAXO INC
Inventor: LACKEY KAREN , LUZZIO MICHAEL JOSEPH , EVANS MICHAEL GLENN , BESTERMAN JEFFREY MARK , STERNBACH DANIEL DAVID , PEEL MICHAEL ROBERT
IPC: A61K20060101 , C07D20060101 , C07D , A61K
-
公开(公告)号:NO924158L
公开(公告)日:1993-04-30
申请号:NO924158
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/4738 , A61K31/47 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:AU6777194A
公开(公告)日:1994-11-21
申请号:AU6777194
申请日:1994-04-28
Applicant: GLAXO INC
IPC: A61K20060101 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18 , C07D491/22
-
公开(公告)号:MX9307011A
公开(公告)日:1994-05-31
申请号:MX9307011
申请日:1993-11-10
Applicant: GLAXO INC
Inventor: BESTERMAN JEFFREY MARK , STERNBACH DANIEL DAVID , PEEL MICHAEL ROBERT , LACKEY KAREN , LUZZIO MICHAEL JOSEPH , EVANS MICHAEL GLENN
IPC: A61K31/47 , A61K31/675 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07F9/6561
Abstract: The present invention relates to water soluble, camptothecin derivatives of formula (I). wherein A represents a moiety of the formula (IIA), (IIB) or (IIC): X is selected from the group consisting of alkyl, aryl, (CH2)mOR1, (CH2)mSR1 and (CH2)mNR1R2 wherein m is an integer of 0 to 6, and R1 and R2 are hydrogen, lower alkyl, aryl or together with the nitrogen form a 5-7 membered ring; q is an integer of 0 to 2; n represents the integer 1 or 2; p is an integer of 1 to 6; Y and W are selected from the group consisting of alkyl, aryl, alkoxy, aryloxy and amino, Q is oxygen or sulfur; P is phosphorus; J represents the atoms necessary to complete a 5 or 6 membered aromatic ring; and the pharmaceutically acceptable salts thereof; their use as topoisomerase inhibitors, their preparation; and their use in the treatment of cancer.
-
公开(公告)号:IS4092A
公开(公告)日:1994-05-13
申请号:IS4092
申请日:1993-11-08
Applicant: GLAXO INC
Inventor: LACKEY KAREN , LUZZIO MICHAEL JOSEPH , EVANS MICHAEL GLENN , BESTERMAN JEFFREY MARK , STERNBACH DANIEL DAVID , PEEL MICHAEL ROBERT
IPC: A61K31/47 , A61K31/675 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07F9/6561
-
公开(公告)号:PL298705A1
公开(公告)日:1994-04-18
申请号:PL29870593
申请日:1993-04-26
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: C07D491/12 , C07D491/22
-
公开(公告)号:CZ9203237A3
公开(公告)日:1993-10-13
申请号:CS323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
CPC classification number: C07D319/18 , C07D317/66
-
公开(公告)号:ZA928324B
公开(公告)日:1993-05-04
申请号:ZA928324
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K20060101 , C07D20060101 , C07D , A61K
-
公开(公告)号:NO924158A
公开(公告)日:1993-04-30
申请号:NO924158
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
CPC classification number: C07D319/18 , C07D317/66
-
公开(公告)号:FI104373B
公开(公告)日:2000-01-14
申请号:FI924878
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61K31/47 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
-
-
-
-
-
-
-
-